Wellfully Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van Wellfully is gedaald met een gemiddeld jaarlijks percentage van -37.1%, terwijl de winst van de Pharmaceuticals -industrie jaarlijks groeide met 35.4%. De inkomsten zijn daalde met een gemiddeld percentage van 4.5% per jaar.

Belangrijke informatie

-37.1%

Groei van de winst

-15.0%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie	31.2%
Inkomstengroei	-4.5%
Rendement op eigen vermogen	n/a
Nettomarge	-469.0%
Laatste winstupdate	31 Dec 2022

Recente prestatie-updates uit het verleden

Recent updates

Opbrengsten en kosten

Hoe Wellfully geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

ASX:WFL Opbrengsten, kosten en inkomsten (AUD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
31 Dec 22	2	-8	7
30 Sep 22	2	-8	7
30 Jun 22	3	-7	7
31 Mar 22	2	-7	7
31 Dec 21	1	-7	7
30 Sep 21	1	-7	6
30 Jun 21	1	-6	6
31 Mar 21	1	-6	5
31 Dec 20	1	-6	5
30 Sep 20	1	-5	5
30 Jun 20	1	-4	4
31 Mar 20	2	-3	4
31 Dec 19	3	-2	4
30 Sep 19	3	-2	4
30 Jun 19	3	-2	4
31 Mar 19	2	-2	3
31 Dec 18	2	-2	3
30 Sep 18	2	-2	3
30 Jun 18	2	-2	3
31 Mar 18	2	-1	3
31 Dec 17	2	-1	2
30 Sep 17	2	-2	3
30 Jun 17	2	-3	4
31 Mar 17	2	-4	5
31 Dec 16	2	-5	5
30 Sep 16	2	-4	5
30 Jun 16	2	-4	4
31 Mar 16	2	-3	4
31 Dec 15	2	-3	3
30 Sep 15	2	-3	3
30 Jun 15	2	-2	3
31 Mar 15	1	-2	3
31 Dec 14	1	-2	3
30 Sep 14	1	-2	3
30 Jun 14	1	-2	3
31 Mar 14	1	-2	2
31 Dec 13	1	-1	2
30 Sep 13	1	-1	2
30 Jun 13	1	-1	2
31 Mar 13	1	-2	2
31 Dec 12	0	-2	2

Kwaliteitswinsten: WFL is momenteel verliesgevend.

Groeiende winstmarge: WFL is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: WFL is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 37.1% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van WFL over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: WFL is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Pharmaceuticals industrie ( 46.5% ).

Rendement op eigen vermogen

Hoge ROE: De schulden van WFL zijn groter dan de activa, dus het is lastig om het rendement op het eigen vermogen te berekenen.

Wellfully Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.019 loss in 1H 2022)

Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)

Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Recent updates

Wellfully Limited, Annual General Meeting, Apr 26, 2024

Wellfully Limited Announces Board Changes

Wellfully Limited Appoints John Forrester as Director

First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.019 loss in 1H 2022)

Wellfully Limited Appoints David Wheeler as Non-Executive Director, Effective from 1 February 2023

Wellfully Limited Announces Step Down of Steven Schapera as Non-Executive Director, Effective 31 December 2022

Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.

Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.

Wellfully Limited Appoints Andy Wortlock as Non-Executive Director

Less than half of directors are independent

Wellfully Limited, Annual General Meeting, Nov 25, 2022

Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)

Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.136528 million.

Wellfully Limited Announces Knee Patch Registered as A Medical Device

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.1 million.

Wellfully Limited announced that it expects to receive AUD 0.1 million in funding

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.13 million.

Wellfully Limited Announces Board Changes

Wellfully Limited Announces Swisswell Knee Patch Successfully Registered as Medical Device in the USA

Less than half of directors are independent

Less than half of directors are independent

Wellfully Limited Announces Board Changes

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Independent Non-Executive Director Cameron Reynolds has left the company

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Wellfully Limited announced that it expects to receive AUD 4.75 million in funding

Wellfully Limited has announced a Derivatives Offering in the amount of AUD 0.112307 million.

Wellfully Limited Announces Business & Operational Update

Wellfully Limited Completes Its Scheduled Release of 20 Launches in 20 Weeks for Its RÉDUIT Brand

Full year earnings released - AU$0.041 loss per share

Wellfully Limited Signs A Content Partnership for Its RÉDUIT Brand with Victoria Beckham

Wellfully Limited Agrees to Supply Terms For, and Launches its Réduit Brand with The Hut Group

Full year earnings released

Opbrengsten en kosten

Inkomsten en omzetgeschiedenis

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Rendement op eigen vermogen

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden